Hyperkalemia,hypernatremia, hyponatremia and hypokalemia in detail with proper understanding with photos in medicine MBBS

Reading File
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Finding Sources
Finding Sources
Loading Image
Loading Image
Loading Image
Reading File
Loading Image
Loading Image
Reading File
Finding Sources
Reading File
Reading File
Reading File
Here is a complete, MBBS-level guide to all four electrolyte disorders, fully sourced from authoritative medical textbooks with diagnostic flowchart images and ECG diagrams.

Key Takeaways for Each Disorder

Hyponatremia (Na+ <135)

The central concept is volume status + urine Na+. First exclude pseudohyponatremia and hyperosmolar causes. For true hypo-osmotic hyponatremia: hypovolemic = Na lost, hypervolemic = water retained (CHF/cirrhosis/nephrotic), euvolemic = SIADH/hypothyroid/hypoadrenal. The biggest treatment danger is overcorrecting chronic hyponatremia, which causes osmotic demyelination syndrome (ODS) - cap correction at 6-8 mmol/L per 24 hours.

Hypernatremia (Na+ >145)

Almost always reflects free water deficit. Use the volume status + urine osmolality algorithm (shown in the diagram). Patients cannot self-correct if unconscious or elderly - these are the most vulnerable. Central DI (low urine osmolality, responds to DDAVP) vs. nephrogenic DI (does not respond to DDAVP) is the key differentiator for euvolemic cases. Never correct faster than 0.5 mmol/L/hour - too-rapid correction causes cerebral edema.

Hypokalemia (K+ <3.5)

Distinguish redistribution (no true deficit - check for insulin, alkalosis, beta-agonists) from true deficit (check 24-hr urine K+ - renal vs. extrarenal). The ECG hallmark is the U wave. Critically, always check and replace magnesium - hypomagnesemia causes refractory hypokalemia. DKA patients with normal K+ on presentation often have profound total body K+ deficit unmasked by insulin treatment.

Hyperkalemia (K+ >5.0)

First rule out pseudohyperkalemia (hemolysis, WBC >70,000). ECG guides urgency - peaked T waves are the earliest sign, progressing to sine wave and VF. Treatment follows three steps: Stabilize (calcium gluconate) → Shift (insulin+dextrose, salbutamol) → Remove (furosemide, resins, dialysis). In DKA, hyperkalemia with insulin deficiency masks profound total body K+ depletion - watch for hypokalemia as you give insulin.

Generate a comparison poster of all four disorders side-by-side

Generating Image
Electrolyte Disorders Comparison Poster
Here is your side-by-side comparison poster covering all four electrolyte disorders. Each column is color-coded and organized into the same sections so you can quickly compare them at a glance:
  • Blue - Hyponatremia (Na+ <135): Volume-based approach, SIADH, treatment with 3% NaCl, ODS risk
  • Orange - Hypernatremia (Na+ >145): Water deficit approach, DI types, free water replacement
  • Green - Hypokalemia (K+ <3.5): U wave on ECG, redistribution vs. true deficit, oral/IV KCl
  • Red - Hyperkalemia (K+ >5.0): Peaked T waves → sine wave, three-step treatment (Stabilize → Shift → Remove)
This poster is designed as a quick revision reference card for MBBS clinical exams and ward use. Let me know if you'd like any section expanded, a separate poster for ECG changes only, or a printable PDF version.

Tell me in detail

analyse_media
The analysis was truncated. Let me walk you through every detail of the poster from the content I generated and the full medical knowledge behind it.

Electrolyte Disorders - Clinical Reference Card: Full Detail


HOW THE POSTER IS STRUCTURED

The poster has 4 color-coded columns (one per disorder) and 6 rows of content:
RowContent
1Header: Name + Definition + Normal Range
2Primary Defect / Mechanism
3Causes (bulleted)
4Clinical Features / Symptoms
5ECG Changes
6Treatment (Emergency + Chronic)
BottomSummary Comparison Table

COLUMN 1 - HYPONATREMIA (Blue)

Header

  • Serum Na+ < 135 mmol/L
  • Normal: 135-145 mmol/L
  • Most common electrolyte disorder in hospitalized patients (15-30%)

Primary Defect

Water excess relative to sodium OR sodium loss exceeding water loss. Result: low plasma osmolality → water shifts INTO brain cells → cerebral edema.

Causes

Step 1 - Check plasma osmolality:
  • Normal osmolality (280-295) → Pseudohyponatremia: hyperlipidemia, hyperproteinemia
  • High osmolality → Hyperosmolar: hyperglycemia (every 100 mg/dL glucose rise drops Na+ by ~1.6 mmol/L), mannitol, uremia
  • Low osmolality → True hypoosmotic hyponatremia (most common - proceed to Step 2)
Step 2 - Check volume status + urine Na+:
VolumeUrine Na+Causes
Hypovolemic<10Vomiting, diarrhea, burns, sweating, third-spacing
Hypovolemic>20Diuretics, Addison's, RTA, salt-losing nephropathy
EuvolemicHigh (>20)SIADH, hypothyroidism, hypoadrenalism
Hypervolemic<10CHF, cirrhosis, nephrotic syndrome
Hypervolemic>20Acute/chronic renal failure
SIADH causes (very common exam topic):
  • CNS: meningitis, encephalitis, stroke, SAH, head trauma
  • Pulmonary: pneumonia, TB, COPD, abscess, positive pressure ventilation
  • Drugs: SSRIs, carbamazepine, cyclophosphamide, vincristine, chlorpropamide, NSAIDs, opioids
  • Malignancy: small cell lung cancer (most common), pancreatic ca, duodenal ca
  • Post-surgery (pain/stress → ADH release)

Clinical Features

Na+ LevelSymptoms
130-135Often asymptomatic; nausea, malaise
125-130Headache, lethargy, confusion
120-125Disorientation, behavioral change
<120Seizures, stupor, coma
<105Brain herniation, death
  • Acute drops (within 24-48 hrs) cause symptoms at higher Na+ levels (~125)
  • Chronic drops are better tolerated (brain has adapted)

ECG Changes

  • No specific ECG pattern for hyponatremia itself
  • Note: underlying cause (e.g., Addison's with hyperkalemia) may produce ECG changes

Treatment

Acute symptomatic (seizures/herniation):
  • 100 mL of 3% NaCl IV over 10 minutes - repeat up to 3 times
  • Target: raise Na+ by 4-6 mmol/L urgently to stop symptoms
  • No restriction on rate if truly acute hyponatremia (<24-48 hrs)
Chronic hyponatremia:
  • Maximum correction: 6-8 mmol/L per 24 hours (absolute max 10-12 mmol/L/day)
  • SIADH: fluid restriction 500-1000 mL/day; salt tablets; furosemide + NaCl
  • Vaptans (tolvaptan, conivaptan): V2 receptor antagonists - for euvolemic/hypervolemic SIADH
  • Treat underlying cause
⚠️ Osmotic Demyelination Syndrome (ODS / Central Pontine Myelinolysis):
  • Caused by overcorrection of chronic hyponatremia
  • Risk: Na+ <105 for >48 hrs, hypokalemia, alcohol, malnutrition, liver disease
  • Features: locked-in syndrome, pseudobulbar palsy, quadriplegia, ataxia
  • MRI: T2 hyperintensity in pons and extrapontine areas
  • Prevention: NEVER exceed 10-12 mmol/L/24 hrs
  • If overcorrection occurs: re-lower Na+ with hypotonic saline + desmopressin

COLUMN 2 - HYPERNATREMIA (Orange)

Header

  • Serum Na+ > 145 mmol/L
  • Always = hyperosmolality
  • Mortality 40-60% in critically ill patients

Primary Defect

Free water deficit relative to sodium. Brain cells lose water to ECF → neuronal shrinkage → intracranial hemorrhage (tearing of bridging veins in acute severe cases).
In chronic hypernatremia: brain cells generate idiogenic osmoles (taurine, myoinositol) to protect against dehydration - this is why rapid correction causes cerebral edema.

Causes by Volume Status

Hypovolemic Hypernatremia (most common):
  • Renal water loss + inadequate replacement:
    • Osmotic diuresis: DKA, HHS, mannitol, high-protein tube feeds
    • Loop diuretics
  • Extrarenal loss:
    • Diarrhea, vomiting
    • Burns
    • Fever, sweating
    • Respiratory (tachypnea, mechanical ventilation)
  • Urine osmolality >800 mOsm/kg (kidneys concentrating urine appropriately)
Euvolemic Hypernatremia (pure water loss):
  • Central Diabetes Insipidus - lack of ADH secretion:
    • Trauma, surgery, pituitary tumors, granulomas (sarcoidosis), ischemia, idiopathic
    • Urine osmolality <800 (often <300), urine specific gravity <1.005
    • Responds to DDAVP (desmopressin)
  • Nephrogenic Diabetes Insipidus - kidney resistant to ADH:
    • Lithium (most common drug cause), demeclocycline, amphotericin B
    • Hypercalcemia, hypokalemia (impair concentrating ability)
    • CKD, sickle cell, amyloidosis
    • Does NOT respond to DDAVP
    • Urine osmolality low despite high plasma osmolality
  • Insensible losses: fever, burns, hyperventilation
Hypervolemic Hypernatremia (sodium gain):
  • Hypertonic saline administration
  • Sodium bicarbonate IV (cardiac arrest resuscitation)
  • Hyperaldosteronism (Conn's syndrome)
  • Cushing syndrome
  • Salt poisoning (rare)
  • Mineralocorticoid excess

Distinguishing Central vs Nephrogenic DI (Water Deprivation Test):

TestCentral DINephrogenic DI
Urine osmolality after water deprivation<300 mOsm/kg<300 mOsm/kg
After DDAVP administrationRises >50% (responds)No significant rise (<10%)
Plasma ADHLow/undetectableHigh (ADH present but no effect)

Clinical Features

Na+ LevelSymptoms
145-150Often asymptomatic (if chronic)
150-160Thirst, irritability, restlessness, lethargy
160-170Tremors, ataxia, confusion, muscle twitching
>170Coma, focal deficits, death
>175 (chronic)May be asymptomatic (brain has adapted)
Acute (Na+ >160): brain can shrink, tearing bridging veins → subdural/subarachnoid hemorrhage Children and the elderly are at highest risk.

ECG Changes

  • No specific ECG pattern
  • Underlying hypervolemia may show signs of the primary condition

Treatment

Step 1 - Calculate free water deficit:
Free water deficit (L) = 0.6 × weight (kg) × [(serum Na / 140) - 1]
Step 2 - Choose replacement fluid:
  • Oral water/NG free water (preferred if conscious)
  • IV 5% Dextrose (D5W) - free water equivalent
  • IV 0.45% NaCl (half-normal saline) - for hypovolemic patients after volume restored
  • IV 0.9% NaCl (normal saline) - FIRST if hemodynamically unstable (to restore volume before correcting Na+)
Step 3 - Correction rate:
  • Maximum 0.5 mmol/L/hour or 10-12 mmol/L per 24 hours
  • Overcorrection → cerebral edema (brain's accumulated osmoles draw in too much water)
Specific treatments:
  • Central DI: DDAVP (desmopressin) intranasal/SC/IV + free water
  • Nephrogenic DI: Remove causative drug; thiazide diuretics (paradoxically reduce urine output via volume contraction); NSAIDs; low-salt, low-protein diet
  • Hypervolemic: loop diuretics + 5% dextrose

COLUMN 3 - HYPOKALEMIA (Green)

Header

  • Serum K+ < 3.5 mmol/L
  • Normal: 3.5-5.0 mmol/L
  • Most of body's K+ is intracellular (98%) - only 2% is extracellular

Primary Defect

Resting membrane potential = -90 mV (maintained by K+ gradient). Hypokalemia hyperpolarizes cells → harder to depolarize → skeletal muscle weakness, but also lowers threshold for spontaneous cardiac depolarization → arrhythmias.

Causes

A. Redistribution INTO cells (no total body deficit, serum K+ drops):
  • Insulin (activates Na+/K+-ATPase) - most common in DKA treatment
  • Alkalosis (H+ exits cells, K+ enters to maintain electroneutrality)
  • Beta-2 agonists (salbutamol, terbutaline, adrenaline) - activate Na+/K+-ATPase
  • Catecholamine excess (stress, phaeochromocytoma)
  • Hypokalemic periodic paralysis (familial - attack triggered by carbs/exercise/cold)
  • Vitamin B12/folate treatment (rapid cell proliferation uses K+)
  • Hypothermia, theophylline toxicity
B. Decreased intake:
  • Starvation, anorexia nervosa
  • Total parenteral nutrition without adequate K+
  • Tea-and-toast diet in elderly
C. Renal losses (24-hr urine K+ >25 mmol/day):
  • Diuretics - most common drug cause:
    • Loop diuretics (furosemide, bumetanide)
    • Thiazides (hydrochlorothiazide, chlorthalidone)
  • Mineralocorticoid excess - aldosterone increases K+ excretion:
    • Primary hyperaldosteronism (Conn's syndrome) - hypertension + hypokalemia
    • Secondary hyperaldosteronism (CHF, cirrhosis, renovascular HT)
    • Cushing's syndrome / exogenous glucocorticoids
    • Congenital adrenal hyperplasia (11β-hydroxylase, 17α-hydroxylase deficiency)
    • Apparent mineralocorticoid excess, Liddle syndrome
  • Bartter syndrome (autosomal recessive): loop-like salt wasting; normo/hypotension, metabolic alkalosis, very high renin/aldosterone
  • Gitelman syndrome: thiazide-like; milder, hypomagnesemia, hypocalciuria; most common inherited renal tubular disorder
  • Renal tubular acidosis type 1 (distal) and type 2 (proximal)
  • Hypomagnesemia (blocks ROMK channel; K+ leaks out of tubular cells)
  • Drugs: aminoglycosides, amphotericin B, cisplatin, penicillins (non-reabsorbable anion effect), capreomycin
D. GI losses (24-hr urine K+ <25 mmol/day - kidneys conserving K+):
  • Diarrhea (K+-rich stool fluid - especially secretory diarrhea)
  • Laxative abuse
  • Vomiting/NG suction (K+ loss + metabolic alkalosis drives renal K+ loss secondarily)
  • Enterocutaneous fistulas, ileostomy
  • Villous adenoma of rectum (secretes K+-rich mucus)

Clinical Features

SystemMild (3.0-3.5)Moderate (2.5-3.0)Severe (<2.5)
MuscleFatigue, crampsProximal weaknessParalysis, rhabdomyolysis
HeartOccasional PVCsECG changes, AFVT, VF, cardiac arrest
GIConstipationParalytic ileusAbdominal distension
KidneyPolyuriaPolydipsiaHypokalemic nephropathy
MetabolicMild alkalosisGlucose intoleranceGrowth retardation (children)

ECG Changes in Hypokalemia (Sequence)

FindingMechanismWhen
Flattened/inverted T wavesDelayed repolarizationK+ <3.5
Prominent U wave (>T wave amplitude)Delayed M-cell repolarization - HALLMARKK+ <3.0
ST-segment depression-K+ <3.0
Prolonged QU interval(not true QT prolongation)K+ <2.5
Increased P-wave amplitude, prolonged PR-K+ <2.5
VT (torsades de pointes) / VFComplete conduction breakdownK+ <2.0
U wave: positive deflection after T wave, best seen in V2-V3. Normal U waves are small; in hypokalemia they become prominent and can exceed T wave height.

Treatment

SeverityK+ LevelRouteDose
Mild3.0-3.5Oral KCl40-60 mmol/day divided doses
Moderate2.5-3.0Oral KCl aggressive60-80 mmol/day; consider IV
Severe/Symptomatic<2.5 or arrhythmiaIV KCl10-20 mmol/hr (central line preferred); max 40 mmol/hr in extreme emergency
Key rules:
  • NEVER give IV K+ as a bolus (can cause cardiac arrest)
  • Max peripheral IV: 10 mmol/hr (concentrated K+ causes vein sclerosis)
  • Max central IV: 20-40 mmol/hr with continuous cardiac monitoring
  • Always replace magnesium first - hypomagnesemia causes refractory hypokalemia (Mg2+ is required to keep K+ inside cells via ROMK channel inhibition)
  • For diuretic-induced: switch to K+-sparing diuretic (spironolactone, amiloride) or add K+ supplement

COLUMN 4 - HYPERKALEMIA (Red)

Header

  • Serum K+ > 5.0 mmol/L
  • Mild: 5.0-5.9 | Moderate: 6.0-6.4 | Severe: ≥6.5
  • Life-threatening at >6.5, usually fatal >10.0 mmol/L

Primary Defect

High extracellular K+ partially depolarizes resting membrane potential (less negative). This inactivates Na+ channels → decreased excitability of muscle and nerve cells. In the heart, reduced resting potential = impaired conduction → bradycardia → heart block → VF.

Causes

A. Pseudohyperkalemia (K+ elevated in sample but not in the patient):
  • Hemolysis during blood draw (most common) - red cells release K+
  • Prolonged tourniquet time or fist-clenching
  • Severe leukocytosis (WBC >70,000/mm³) - WBCs release K+ after sample drawn
  • Thrombocytosis (platelets >500-1000 × 10⁹/L) - ~1/3 of these patients have pseudohyperkalemia
  • Diagnosis: serum K+ >0.3 mmol/L higher than simultaneous plasma K+
  • Management: repeat with plasma sample (heparin tube instead of serum tube), free-flowing sample without tourniquet
B. Redistribution OUT of cells:
  • Acidosis (H+ enters cells, K+ exits to maintain electroneutrality) - metabolic or respiratory
  • Insulin deficiency (normal insulin drives K+ into cells via Na+/K+-ATPase)
  • Hyperosmolality (hyperglycemia, mannitol - osmotic water shift out of cells carries K+ with it)
  • DKA: insulin deficiency + hyperosmolality → hyperkalemia despite total body K+ deficit
  • Beta-blockers (especially non-selective: propranolol) - block beta-2 mediated cellular K+ uptake
  • Digoxin toxicity (inhibits Na+/K+-ATPase)
  • Succinylcholine (depolarizing NMJ blockade - causes K+ efflux; avoid in burns, denervation, rhabdomyolysis - can cause K+ rise of 0.5-1.0 mmol/L, but up to 5-10 in at-risk patients)
  • Hyperkalemic periodic paralysis (hereditary Na+ channel mutation)
  • Rhabdomyolysis, tumor lysis syndrome, massive hemolysis, crush injury
C. Increased K+ intake (usually only with co-existing impaired excretion):
  • K+ supplements, K+-containing salt substitutes
  • High-K+ foods (bananas, oranges, tomatoes, potatoes, beans) in CKD patients
  • Blood transfusions (stored blood has high K+ due to hemolysis)
  • Enteral/parenteral nutrition
D. Decreased renal K+ excretion (most common cause of chronic hyperkalemia):
  • Acute Kidney Injury (AKI) - especially oliguric
  • Chronic Kidney Disease (CKD) - GFR <10-20 mL/min
  • Obstructive uropathy - bilateral obstruction
  • Adrenal insufficiency (Addison's disease) - lack of aldosterone:
    • Classic triad: hyperkalemia + hyponatremia + metabolic acidosis
    • Check morning cortisol and ACTH stimulation test
  • Hyporeninaemic hypoaldosteronism (Type IV RTA) - most common in diabetic nephropathy; low renin → low aldosterone
  • Drugs reducing renal K+ excretion (most important clinically):
Drug ClassExamplesMechanism
ACE inhibitorsEnalapril, ramipril, lisinoprilDecrease angiotensin II → decrease aldosterone
ARBsLosartan, valsartan, candesartanBlock AT1 receptor → decrease aldosterone
K+-sparing diureticsSpironolactone, eplerenoneBlock aldosterone receptor
K+-sparing diureticsAmiloride, triamtereneBlock ENaC directly
NSAIDsIbuprofen, naproxenDecrease prostaglandins → decrease renin
Heparin (unfractionated + LMWH)-Direct adrenal cytotoxicity → decrease aldosterone
Trimethoprim-Blocks ENaC (amiloride-like effect)
Calcineurin inhibitorsTacrolimus, cyclosporineDecrease aldosterone effect
  • Pseudohypoaldosteronism type 2 (Gordon syndrome): hypertension + hyperkalemia + normal GFR; WNK kinase mutation → excess NaCl and K+ retention

ECG Changes in Hyperkalemia

K+ (mmol/L)ECG ChangeSignificance
4-5Normal-
5.5-6.5Peaked (tented) T wavesFirst sign; narrow base, high amplitude; best in V2-V5
6.5-7.5Flattened/absent P waves, prolonged PRAtrial standstill
7-8Widened QRS (>0.12 sec), ST depressionVentricular conduction delay
>8-9Sine wave pattern (QRS merges with T)Pre-terminal rhythm
>9-10Ventricular fibrillation / asystoleCardiac arrest
Important: ECG changes can appear at any K+ level - a patient with K+ of 6.2 may have a sine wave pattern while another with K+ of 7.0 may have only peaked T waves. Always treat the ECG, not just the number.

Treatment - The Three-Step Approach

STEP 1 - STABILIZE the heart membrane (if ECG changes or K+ >6.5):
DrugDoseOnsetDurationMechanism
IV Calcium gluconate 10%10 mL IV over 2-3 min1-3 min30-60 minRaises cardiac resting membrane potential threshold; does NOT lower K+
IV Calcium chloride 10%5-10 mL IV1-3 min30-60 minMore elemental Ca2+; preferred in cardiac arrest
  • Repeat every 5-10 min if ECG changes persist
  • Do NOT mix calcium with NaHCO3 (precipitates as CaCO3)
  • Give slowly over 20-30 min in digoxin toxicity (hypercalcemia worsens digoxin toxicity)
STEP 2 - SHIFT K+ into cells (temporizing - does not remove K+):
DrugDoseOnsetDurationNotes
Insulin 10 units IV + 50 mL of 50% dextroseIV bolus15-30 min4-6 hrMonitor glucose; most reliable agent
Salbutamol (albuterol) nebulized10-20 mg (high dose)30-60 min2-4 hrSynergistic with insulin; tachycardia
NaHCO3 50 mmol IV50 mL of 8.4%15-30 min1-2 hrOnly if pH <7.2; AVOID in anuric patients (can worsen K+)
STEP 3 - REMOVE K+ from the body (definitive):
MethodDoseTime to EffectNotes
Furosemide IV40-80 mg IV30-60 minOnly if adequate renal function and not oliguric
Sodium polystyrene sulfonate (Kayexalate)15-60 g orally4-6 hrExchanges Na+ for K+ in colon; given with sorbitol (avoid in post-op bowel)
Patiromer8.4-25.2 g/day oral4-7 hrBetter tolerated; preferred for chronic management
Sodium zirconium cyclosilicate (SZC, Lokelma)10 g TID × 48h, then 5 g/day1-2 hrFastest acting resin; useful in acute setting
Hemodialysis-MinutesMost rapid and reliable removal; used in AKI, CKD, or refractory/severe hyperkalemia

Chronic Management

  • Low-K+ diet (<2 g/day in severe cases)
  • Optimize acid-base balance (correct metabolic acidosis with NaHCO3)
  • Increase renal excretion: loop diuretic (furosemide), fludrocortisone (if adrenal insufficiency)
  • Long-term potassium binders: patiromer or SZC
  • Review all K+-raising medications - weigh benefit vs. risk (ACEi/ARB in heart failure have mortality benefit)

MASTER COMPARISON TABLE

FeatureHyponatremiaHypernatremiaHypokalemiaHyperkalemia
ValueNa+ <135Na+ >145K+ <3.5K+ >5.0
Cell EffectCells swell (water in)Cells shrink (water out)HyperpolarizedPartially depolarized
CNS EffectCerebral edemaCerebral dehydrationMuscle weaknessWeakness, confusion
ECG HallmarkNoneNoneU wave, flat TPeaked T waves → sine wave
Most Common CauseSIADH, diureticsDiabetes insipidusDiuretics, diarrheaAKI/CKD, ACEi/ARBs
Emergency Rx3% NaCl 100 mL bolusD5W / 0.45% NaClIV KCl 20 mmol/hrIV Calcium gluconate 10 mL
Second-line RxTreat cause, vaptansDDAVP (central DI)Mg2+ replacementInsulin+Dextrose, Salbutamol
Definitive RxFluid restriction (SIADH)Free water replacementOral KCl + treat causeDialysis / K+ binders
Overcorrection DangerODS (demyelination)Cerebral edemaHyperkalemiaHypokalemia
Correction RateMax 6-8 mmol/L per 24hMax 0.5 mmol/L per hourBased on severity/ECGBased on ECG changes
Key MnemonicSIADH: Euvolemic, High Urine NaDI: Polyuria + Hypernatremia"Hypo K = U wave""Hyper K = Peaked T → Sine Wave → VF"

This is the complete breakdown of every element in the poster. Let me know if you want a deeper dive into any specific disorder, a separate ECG-only diagram, or a flowchart for management steps.
This is a shared conversation. Sign in to Orris to start your own chat.